The highest-leverage bet in the whole market is not AI, it's LSD
You Have No Idea How Big DFTX Is Going to BeThe highest-leverage bet in the whole market is not AI, it's LSD.AndyJul 26, 20261ShareLook, I’m not trying to convince you that psychedelics are the next big thing. That’s 43.17 dollars a share times 132.74M shares. The company has no revenue, which, don’t get me wrong, is pretty common for a biotech startup, but anyway, they estimate $4.9B potential revenue for every 100,000 patients treated with DT120.From Definium Therapeutics’ Corporate Presentation, page 36:So what’s the big deal?
- ▪You Have No Idea How Big DFTX Is Going to BeThe highest-leverage bet in the whole market is not AI, it's LSD.AndyJul 26, 20261ShareLook, I’m not trying to convince you that psychedelics are the next big thing.
- ▪That’s 43.17 dollars a share times 132.74M shares.
- ▪The company has no revenue, which, don’t get me wrong, is pretty common for a biotech startup, but anyway, they estimate $4.9B potential revenue for every 100,000 patients treated with DT120.From Definium Therapeutics’ Corporate Presentatio
Hacker News (AI / LLM) files mainly under ai. We currently carry 3,346 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Hacker News (AI / LLM) |
| Canonical URL | https://www.singularityrainbow.ai/p/you-have-no-idea-how-big-dftx-is |
| Publication time | Sun, 26 Jul 2026 22:23:18 +0000 |
| Retrieval time | 2026-07-26T22:28:27.549Z |
| Last seen | 2026-07-26T22:28:27.549Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | qPyPdx0W4gCG |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
You Have No Idea How Big DFTX Is Going to BeThe highest-leverage bet in the whole market is not AI, it's LSD.AndyJul 26, 20261ShareLook, I’m not trying to convince you that psychedelics are the next big thing. I already did that. I’m trying to convince you that psychedelics, and in particular, LSD, and in particular Definium Therapeutics (which is the company behind DT120, Definium Therapeutics’ proprietary formulation of LSD) is going to make you rich.And I mean obscenely rich.And sure, I know what you’re thinking — with these premises I wouldn’t believe you either.So, let’s do some math (this article is going to be very short).Right now, Definium Therapeutics (ticker DFTX) is worth $5.731B. That’s 43.17 dollars a share times 132.74M shares.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Hacker News (AI / LLM).
Discussion
0 commentsMore from Hacker News (AI / LLM)
